The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2023 | AI improving CXR reporting
Nick Woznitza, MBE, PhD, FBIR, FCR, MASMIRT(AP), University College London Hospitals NHS Foundation Trust, London, UK, comments on the exciting progression of AI diagnostic tools from use in controlled clinical studies to use in real-world clinical settings. One such tool is qXR, an AI tool which is soon to be employed clinically with the aim of diagnosing lung cancer earlier. This interview took place at the British Thoracic Oncology Group (BTOG) Annual Conference 2023 in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
